The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $1.75 for the day, down -6.42% from the previous closing price of $1.87. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 4041809 shares were traded.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.61 and its Current Ratio is at 17.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 15 ’23 when WEAVER GREGORY L sold 50,000 shares for $0.65 per share. The transaction valued at 32,500 led to the insider holds 55 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 219.28M and an Enterprise Value of 130.82M.
Stock Price History:
Over the past 52 weeks, ATOS has reached a high of $2.31, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is 1.2410, while the 200-Day Moving Average is calculated to be 0.9524.
Shares Statistics:
ATOS traded an average of 1.31M shares per day over the past three months and 3.95M shares per day over the past ten days. A total of 125.30M shares are outstanding, with a floating share count of 125.28M. Insiders hold about 0.02% of the company’s shares, while institutions hold 19.14% stake in the company. Shares short for ATOS as of Mar 15, 2024 were 8.48M with a Short Ratio of 6.49, compared to 7.04M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.77% and a Short% of Float of 6.77%.
Earnings Estimates
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.07, while EPS last year was -$0.05. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.25 and -$0.31 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is -$0.3, with 3 analysts recommending between -$0.28 and -$0.35.
